Mark Urtz brings over 30 years of experience in preclinical research, spanning both academia and industry. He served as the CEO of a leading CRO, where he oversaw numerous GLP and non-GLP studies for medical device and biotechnology companies. During his career, Mark has performed thousands of interventional procedures, including coronary and peripheral interventions, electrophysiology, renal denervation, valve placement, neuromodulation, and more. Mark has traveled nationally and internationally, working with some of the largest medical device companies to evaluate and implement novel technologies. He now offers his expertise through consulting, helping clients navigate regulatory milestones and achieve their preclinical goals. His focus on client satisfaction and collaboration ensures that every project meets the highest standards in technical execution and study outcomes.

• Interventional Expertise & Techniques:
  Mark has performed over 15,000 interventional procedures, specializing in coronary and peripheral interventions, electrophysiology, renal denervation, valve placement, neuromodulation, and other advanced techniques.
• Surgical Procedures:
  Extensive experience performing high-volume interventional procedures, including valve delivery and accessing unique vasculature using advanced imaging modalities like fluoroscopy, IVUS, OCT, and intracardiac echo.
• Data Collection & Analysis:
  Mark is highly experienced in data collection for both GLP and non-GLP studies intended for FDA submissions. He has expertise in analyzing ECG data, including arrhythmias such as atrial fibrillation, heart rate variability, and premature ventricular contractions (PVC), ensuring that data aligns with regulatory standards.
• Training & Mentorship:
  Mark provides training on interventional techniques, including percutaneous sheath access and the use of advanced medical devices. He has trained countless professionals in the use of cutting-edge technologies in preclinical studies.
• Consulting & Study Design:
  With decades of experience, Mark has provided consulting services on study design, protocol development, and product testing for both national and international medical device companies. His leadership in transforming a lab into a globally recognized facility underscores his expertise in executing complex projects from concept to completion.

Mark’s passion for preclinical research is driven by a desire to push the boundaries of medical device testing through innovative interventional techniques and exceptional client service. With extensive experience in both academic and industry settings, Mark has a unique ability to understand the needs of his clients and deliver results that meet the highest regulatory and scientific standards. His leadership has been pivotal in creating a collaborative, client-focused atmosphere where excellence is the expectation.

Training
Experimental Design
Surgery
Data Acquisition
Data Analysis
Data Interpretation
Report Generation

Fluoroscopy
IVUS
OCT
Intracardiac Echo
ECG Monitoring